Our team uses decision analysis tools such as traditional epidemiological studies, clinical trials, meta-analysis, or mathematical modelling to evaluate interventions designed for infectious diseases prevention, control, and care. We evaluate effectiveness of these strategies but also other outcomes such as quality of life and cost in the short but also in the long-term. Moreover, we assess how we should implement these interventions. Our research is focused on HIV, HCV, and health-care associated and multidrug bacterial resistance infections.
Our research goal is to respond to questions regarding infectious disease clinical care at an individual level (i.e.; what is the most efficacious intervention) but also to address questions regarding policy. The ultimate aim of the latest is to impact the decision-making process (what is the most efficient intervention? how the best resources should be used?). Thus, our research address questions currently confronting physicians, patients, but also policy makers.